114 related articles for article (PubMed ID: 9701497)
1. Actinomycin D specifically inhibits the interaction between transcription factor Sp1 and its binding site.
Czyz M; Gniazdowski M
Acta Biochim Pol; 1998; 45(1):67-73. PubMed ID: 9701497
[TBL] [Abstract][Full Text] [Related]
2. Site-specific inhibition of transcription factor binding to DNA by a metallointercalator.
Odom DT; Parker CS; Barton JK
Biochemistry; 1999 Apr; 38(16):5155-63. PubMed ID: 10213621
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
[TBL] [Abstract][Full Text] [Related]
4. Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding.
Bachur NR; Johnson R; Yu F; Hickey R; Applegren N; Malkas L
Mol Pharmacol; 1993 Nov; 44(5):1064-9. PubMed ID: 8246909
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor signalling in endothelial cell survival: a role for NFkappaB.
Grosjean J; Kiriakidis S; Reilly K; Feldmann M; Paleolog E
Biochem Biophys Res Commun; 2006 Feb; 340(3):984-94. PubMed ID: 16410078
[TBL] [Abstract][Full Text] [Related]
6. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
Lu X; Farmer P; Rubin J; Nanes MS
J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
[TBL] [Abstract][Full Text] [Related]
7. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
Wagner AH; Schwabe O; Hecker M
Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor binding study by capillary zone electrophoretic mobility shift assay.
Ronai Z; Wang Y; Khandurina J; Budworth P; Sasvari-Szekely M; Wang X; Guttman A
Electrophoresis; 2003 Jan; 24(1-2):96-100. PubMed ID: 12652578
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
11. Verotoxin-1 induces tissue factor expression in human umbilical vein endothelial cells through activation of NF-kappaB/Rel and AP-1.
Ishii H; Takada K; Higuchi T; Sugiyama J
Thromb Haemost; 2000 Oct; 84(4):712-21. PubMed ID: 11057875
[TBL] [Abstract][Full Text] [Related]
12. Ets-1 stimulates platelet-derived growth factor A-chain gene transcription and vascular smooth muscle cell growth via cooperative interactions with Sp1.
Santiago FS; Khachigian LM
Circ Res; 2004 Sep; 95(5):479-87. PubMed ID: 15297375
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.
Yan Y; Dalmasso G; Sitaraman S; Merlin D
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546
[TBL] [Abstract][Full Text] [Related]
14. Metal ions alter lipopolysaccharide-induced NF kappa B binding in monocytes.
Lewis JB; Wataha JC; Randol TM; McCloud VV; Lockwood PE
J Biomed Mater Res A; 2003 Dec; 67(3):868-75. PubMed ID: 14613235
[TBL] [Abstract][Full Text] [Related]
15. Nuclear receptors modulate the interaction of Sp1 and GC-rich DNA via ternary complex formation.
Husmann M; Dragneva Y; Romahn E; Jehnichen P
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):763-72. PubMed ID: 11104684
[TBL] [Abstract][Full Text] [Related]
16. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
17. Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.
Magan N; Szremska AP; Isaacs RJ; Stowell KM
Biochem J; 2003 Sep; 374(Pt 3):723-9. PubMed ID: 12769819
[TBL] [Abstract][Full Text] [Related]
18. [Actinomycin DO inhibition of RNA biosynthesis and its interaction with DNA preparations].
Devan ML; Orlova TI; Silaev AB
Antibiotiki; 1975 Mar; 20(3):243-8. PubMed ID: 806255
[TBL] [Abstract][Full Text] [Related]
19. Modulation of DNA-protein interactions in the P1 and P2 c-myc promoters by two intercalating drugs.
Vaquero A; Portugal J
Eur J Biochem; 1998 Jan; 251(1-2):435-42. PubMed ID: 9492315
[TBL] [Abstract][Full Text] [Related]
20. Effects of anticancer drugs on transcription in vitro.
Wilmańska D; Czyz M; Studzian K; Piestrzeniewicz MK; Gniazdowski M
Z Naturforsch C J Biosci; 2001; 56(9-10):886-91. PubMed ID: 11724400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
